BHARAT PARENTERALS LIMITEDBB

BHARAT PARENTERALS LIMITED

987.45INRD
−7.75−0.78%
At close at Mar 28, 11:08 GMT
INR
No trades
See on Supercharts

BPLPHARMA fundamentals

Key facts

Market capitalization‪6.81 B‬INR
Basic EPS (TTM)−12.26INR
Founded1992
CEOBharatkumar R. Desai
About

Bharat Parenterals Ltd. engages in the manufacture of pharmaceutical formulations. Its products include general medicines, B-Lactam, cephalosporins, anti-retroviral and veterinary medicines. The company was founded by Ramesh Desai on September 3, 1992 and is headquartered in Vadodara, India.

Ownership
‪‪6.89 M‬‬
Closely held shares
‪‪4.26 M‬‬ (61.76%)
Free Float shares
‪‪2.64 M‬‬ (38.24%)
Closely held shares
‪‪4.26 M‬‬ (61.76%)
Free Float shares
‪‪2.64 M‬‬ (38.24%)
Capital structure
Market cap
‪‪6.81 B‬‬
Enterprise value
‪‪6.81 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪6.81 B‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
2.25x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
2.25x
Valuation ratios
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪0.90‬
‪1.80‬
‪2.70‬
‪3.60‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−12%‬
‪−6%‬
‪0%‬
‪6%‬
‪12%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−350.00 M‬‬
‪0.00‬
‪‪350.00 M‬‬
‪‪700.00 M‬‬
‪‪1.05 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−250.00 M‬‬
‪0.00‬
‪‪250.00 M‬‬
‪‪500.00 M‬‬
‪‪750.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−250.00 M‬‬
‪0.00‬
‪‪250.00 M‬‬
‪‪500.00 M‬‬
‪‪750.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Pharmaceuticals Formulations
Services
Other
By country
Period: 2023
International
India

Dividends

Dividend yield, history and sustainability

Dividend summary
−8.15%
Payout ratio (TTM)
Dividend yield TTM
0.10%
Last payment
1.00
Last ex-date
Jun 25, 2024
Dividend history
‪0.00%‬
‪0.06%‬
‪0.12%‬
‪0.18%‬
‪0.24%‬
2019
2020
2021
2022
2023
‪0.00‬
‪0.25‬
‪0.50‬
‪0.75‬
‪1.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪400.00 M‬‬
‪‪800.00 M‬‬
‪‪1.20 B‬‬
‪‪1.60 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
Assets
Liabilities